Company Focus
BioNTech
Latest BioNTech News
Biotechnology
Although it is seeing a downturn in sales and profits, German biotech BioNTech is continuing to acquire assets with the cash pile it made through the covid pandemic, notably iis Comirnaty vaccine that was developed with Pfizer (NYSE: PFE). 13 November 2024
Related News
Insights
Company Spotlight
A clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies for the treatment of cancer and infectious
diseases
Latest News & Features of interest to BioNTech
Biotechnology
BioNTech (Nasdaq: BNTX) and MediLink Therapeutics have resumed recruitment for their Phase I trial of BNT326/YL202, following the US Food and Drug Administration's decision to lift a partial clinical hold. 19 August 2024
Biotechnology
US pharma giant Pfizer and German partner BioNTech today announced mixed top-line results from their Phase III clinical trial to evaluate the companies’ combined mRNA vaccine candidate against influenza and COVID-19 in healthy individuals 18-64 years of age. 16 August 2024
Pharmaceutical
Denmark-based Bavarian Nordic, the only drugmaker with a US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approved mpox vaccine, saw its shares climb a further 14% to 274.10 kroner this morning, having risen 17% the day before, after the World Health Organization (WHO) declared an escalating mpox outbreak in Africa as a public health emergency. 16 August 2024
Pharmaceutical
Prolific Machines, a US biotech seeking to harness light to deliver unprecedented cellular control, has received a grant from the Bill and Melinda Gates Foundation to use its platform to produce more affordable monoclonal antibodies (mAbs). 15 August 2024
Pharmaceutical
The World Health Organization (WHO) has declared the ongoing surge of mpox cases in the Democratic Republic of the Congo (DRC) and other African countries a public health emergency of global concern. 15 August 2024
Pharmaceutical
Pharmaceutical companies supplying products under the UK’s freshly-launched antibiotics subscription model must now certify compliance with a new industry standard. 14 August 2024
Pharmaceutical
An Expert View from the new chief executive of Gavi, the Vaccine Alliance, Sania Nishtar. 13 August 2024
Biotechnology
Australian biotech CSL Limited today reported revenue of A$14.8 billion (US$9.7 billion) for the 12 months ended June 30, 2024. 13 August 2024
Biotechnology
SpyBiotech, a UK biotech with a novel vaccine platform technology that can target infectious diseases, cancer and chronic diseases, has appointed Prakash Bhuyan as chief medical officer (CMO). 12 August 2024
Latest In Brief for BioNTech
Pharmaceutical
GSK has announced its largest US manufacturing investment to date, dedicated to producing medicines and vaccines. 25 October 2024
Latest Relevant Ones To Watch News
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
18 October 2024
23 September 2024
19 September 2024
16 September 2024
8 August 2024
Relevant Ones to Watch Companies
Refine Search
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze